{"product_id":"anti-human-nectin-4-monoclonal-antibody-enfortumab-ua016187","title":"Anti-Human Nectin-4 Monoclonal Antibody (Enfortumab)","description":"\u003ch4\u003eProduct Specification\u003c\/h4\u003e\u003cdiv class=\"responsive-table product-detail-table details-table\"\u003e\n\u003cbr\u003e\u003ctable style=\"width: 100%; height: auto;\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eHost\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eHuman\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eEnfortumab\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eConcentration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e2mg\/mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eExpression System\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eHEK293\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eConjugation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eUnconjugated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePhysical Appearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eLiquid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStorage Buffer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003ePBS pH7.4, containing no preservative\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStability \u0026amp; Storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\n\u003cp\u003e\u003cspan\u003e2 to 8 °C for 2 weeks under sterile conditions;\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e-20 °C for 3 months under sterile conditions; \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e-80 °C for 24 months under sterile conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePlease avoid repeated freeze-thaw cycles.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eReference\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003e1.Yamada, Riko,Takamura, Saori,Fukuda, Tomoo.Enfortumab Vedotin-Related Cutaneous Adverse Events: Two Cases Highlighting Ring Mitosis and Severity-Guided Management[J].The Journal of Dermatology,2026,53(6):e465-e467.\u003cbr\u003e2.Challita-Eid PM, Satpayev D, Yang P, An Z, Morrison K, Shostak Y, Raitano A, Nadell R, Liu W, Lortie DR, Capo L, Verlinsky A, Leavitt M, Malik F, Aviña H, Guevara CI, Dinh N, Karki S, Anand BS, Pereira DS, Joseph IB, Doñate F, Morrison K, Stover DR. Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models. Cancer Res. 2016 May 15;76(10):3003-13.\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003c\/div\u003e\u003ch4\u003eBackground\u003c\/h4\u003e\u003cdiv\u003e\u003cp\u003e\u003cspan\u003eEnfortumab Vedotin (EV), as a Nectin-4-targeting antibody-drug conjugate (ADC), derives its core value from the precise delivery of a microtubule inhibitor to tumor cells. Beyond exerting direct cytotoxicity through Nectin-4 targeting, EV synergizes with immune checkpoint inhibitors to enhance T cell-mediated antitumor immune responses. The regimens of EV monotherapy and its combination with pembrolizumab have fundamentally revolutionized the treatment landscape of urothelial carcinoma, significantly prolonging overall survival in the first-line setting and demonstrating promising potential for deep downstaging and prognostic improvement in the perioperative setting. However, its distinctive cutaneous and peripheral neurotoxicities warrant close monitoring and meticulous management in clinical practice.\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e","brand":"UA BIOSCIENCE","offers":[{"title":"25μL","offer_id":42981650661451,"sku":"UA016187-25μL","price":50.0,"currency_code":"USD","in_stock":true},{"title":"100μL","offer_id":42981650694219,"sku":"UA016187-100μL","price":110.0,"currency_code":"USD","in_stock":true},{"title":"500μL","offer_id":42981650726987,"sku":"UA016187-500μL","price":335.0,"currency_code":"USD","in_stock":true},{"title":"1mL","offer_id":42981650759755,"sku":"UA016187-1mL","price":600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/8375\/1499\/files\/AntBioImage_0d01b153-1971-44a8-8f50-de7bca646c98.png?v=1785834034","url":"https:\/\/www.antbioinc.com\/products\/anti-human-nectin-4-monoclonal-antibody-enfortumab-ua016187","provider":"AntBio","version":"1.0","type":"link"}